ERGIC3 antibody
Principal name
ERGIC3 antibody
Alternative names for ERGIC3 antibody
C20orf47, ERV46, SDBCAG84, CGI-54, PRO0989, NY-BR-84, Endoplasmic reticulum-Golgi intermediate compartment protein 3, Serologically defined breast cancer antigen NY-BR-84
Ncbi ID
9606, NP_057050, NP_057050.1, NM_198398, NP_938408, NP_079792.1, BC057130, NM_025516, NM_015966
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P)
Background of ERGIC3 antibody
- Kit Component:
- - KN204084G1, ERGIC3 gRNA vector 1 in pCas-Guide vector
- KN204084G2, ERGIC3 gRNA vector 2 in pCas-Guide vector
- KN204084D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Nishikawa,M., et.al., Gene 386 (1-2), 42-51 (2007)
Breuza,L., et.al., J. Biol. Chem. 279 (45), 47242-47253 (2004).
Human HepG2; WB Suggested Anti-ERGIC3 Antibody Titration: 0.2-1 ug/ml. Positive Control: HepG2 cell lysate. ERGIC3 is supported by BioGPS gene expression data to be expressed in HepG2.; ERGIC3 antibody - C-terminal region (ARP47209_P050) in Human HepG2 cells using Western Blot
Formalin-fixed and paraffin-embedded human hepatocarcinoma reacted with ERGIC3 Antibody (N-term) Cat.-No AP51453PU-N, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining.
Western blot analysis of ERGIC3 (arrow) using ERGIC3 Antibody (N-term) Cat.-No AP51453PU-N. 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the ERGIC3 gene.
Western blot analysis of ERGIC3 Antibody (N-term) Cat.-No AP51453PU-N in HepG2 cell line lysates (35ug/lane). ERGIC3 (arrow) was detected using the purified Pab.
WB Suggested Anti-ERGIC3 Antibody Titration: 0.2-1 ug/ml; Positive Control: HepG2 cell lysate.ERGIC3 is supported by BioGPS gene expression data to be expressed in HepG2
Western blot analysis on LOVO cell lysate using ERGI3 Antibody
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA347733 | ERGIC3 antibody |
||||||
| Rabbit Polyclonal Anti-ERGI3 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | WB |
0.1 mg /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP51453PU-N | ERGIC3 (N-term) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu | P, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
 +2 additional images |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP304084 | ERGIC3 (transcript variant 2) |
||||
| Recombinant protein of human ERGIC and golgi 3 (ERGIC3), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP322204 | ERGIC3 (transcript variant 1) |
||||
| Recombinant protein of human ERGIC and golgi 3 (ERGIC3), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY405049 | ERGIC3 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR206158L2V | Lenti ORF particles, Ergic3 (GFP-tagged) - Mouse ERGIC and golgi 3 (cDNA clone MGC:61258 IMAGE:6819420), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,240.00
|
|
| OriGene Technologies, Inc. | ||
| MR206158L1V | Lenti ORF particles, Ergic3 (Myc-DDK-tagged) - Mouse ERGIC and golgi 3 (cDNA clone MGC:61258 IMAGE:6819420), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||
